Clínic Barcelona
Clínic Barcelona
Research
March 6 2024
A European study in people with the participation of Clínic-IDIBAPS shows that treatment with the drug Abatacept reduces the risk of developing rheumatoid arthritis
Published in the journal The Lancet, the study presents the results of Abatacept, a drug that modulates the activation of T cells, which play a key r1